Survey of Korean dentists on the awareness on bisphosphonate‐related osteonecrosis of the jaws

Aim: This survey evaluates the awareness of bisphosphonate‐related osteonecrosis of the jaws among Korean dentists. Methods: We prepared a questionnaire based on bisphosphonate‐related osteonecrosis of the jaw guidelines, suggested by The American Association of Oral Maxillofacial Surgeons. Among 13 405 dentists, we randomly selected 264 (2%) practitioners. Results: A total of 56.5% of respondents had heard of bisphosphonates asmedication related to osteonecrosis, but only 31.4% routinely recorded bisphosphonate medication history. The cross‐sectional analysis demonstrated that most dentists were unaware of The American Association of Oral Maxillofacial Surgeons’ guidelines. Dentists with <5 years’ clinical experience were significantly more aware than those with >5 years’ experience. Experience with treating osteonecrosis of the jaw patients and recording medication histories were significantly greater in dental hospitals with >300 beds or university hospitals. Awareness of the severity of bisphosphonate‐related osteonecrosis of the jaws was greatest among oral surgeons. Conclusion: Dentists should thoroughly check patients’ medical histories, including bisphosphonate intake. With the exception of oral surgeons, most Korean dentists were not adequately aware of bisphosphonate‐related osteonecrosis of the jaws and its seriousness, making it a potential risk in Korean dentistry. Therefore, it is important to educate clinicians regarding the potential risk of bisphosphonate medication in dentistry through education programs.